Presentations Company Presentation – May 2026 November 2025 Corporate Update Webcast Webcast Presentation at H.C. Wainwright 27th Annual Global Investment Conference Virtual Investor Closing Bell Webull Corporate Connect Webinar Series: Biotech3 Welcome from Abizer Gaslightwala, President and CEO Top 5 for ‘25” On-Demand Conference GA Poster – ARVO – May 2024 Trop2 ADC Poster – AACR – April 2023 PHP-303 Neutrophil Elastase Inhibitor Poster – International Symposium Neutrophil 2022 Splicing modulator-based ADC payload class Poster – AACR – April 2021 GA Poster - Hanson-Wade - Oct 2023 Clinical Response to Nomacopan in the Paediatric HSCT-TMA Setting Poster American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Compassionate Use of Nomacopan for COVID-19 (CORONET)” American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Identification of Clinical Deterioration Risk in COVID-19 (CASCADE)” Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 presentation: “Comparison of topical nomacopan, a dual complement and leukotriene LTB4 inhibitor, with dexamethasone in downregulating experimental immune-mediated conjunc Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 poster: “Development of long-acting PAS-nomacopan for treatment of GA and other retinal diseases 5th Annual Complement-based Drug Development Summit 2021 Allergy article International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium 2021 Poster Extract of Tim Higenbottam's presentation at the ARDS Drug Development Summit 2021 American Academy of Dermatology Association (AAD) Meeting April 2021 poster Topline Phase II Results Nomacopan for Treatment of Bullous Pemphigoid EAVD Congress 2019 Presentation – October 2019 ARVO 2019 Poster – April 2019 EHA 2018 Poster ARVO 2018 Poster EHA Poster Tools Print Page Email Alerts RSS Feeds Contact Us
Presentations Company Presentation – May 2026 November 2025 Corporate Update Webcast Webcast Presentation at H.C. Wainwright 27th Annual Global Investment Conference Virtual Investor Closing Bell Webull Corporate Connect Webinar Series: Biotech3 Welcome from Abizer Gaslightwala, President and CEO Top 5 for ‘25” On-Demand Conference GA Poster – ARVO – May 2024 Trop2 ADC Poster – AACR – April 2023 PHP-303 Neutrophil Elastase Inhibitor Poster – International Symposium Neutrophil 2022 Splicing modulator-based ADC payload class Poster – AACR – April 2021 GA Poster - Hanson-Wade - Oct 2023 Clinical Response to Nomacopan in the Paediatric HSCT-TMA Setting Poster American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Compassionate Use of Nomacopan for COVID-19 (CORONET)” American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Identification of Clinical Deterioration Risk in COVID-19 (CASCADE)” Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 presentation: “Comparison of topical nomacopan, a dual complement and leukotriene LTB4 inhibitor, with dexamethasone in downregulating experimental immune-mediated conjunc Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 poster: “Development of long-acting PAS-nomacopan for treatment of GA and other retinal diseases 5th Annual Complement-based Drug Development Summit 2021 Allergy article International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium 2021 Poster Extract of Tim Higenbottam's presentation at the ARDS Drug Development Summit 2021 American Academy of Dermatology Association (AAD) Meeting April 2021 poster Topline Phase II Results Nomacopan for Treatment of Bullous Pemphigoid EAVD Congress 2019 Presentation – October 2019 ARVO 2019 Poster – April 2019 EHA 2018 Poster ARVO 2018 Poster EHA Poster
American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Compassionate Use of Nomacopan for COVID-19 (CORONET)”
American Thoracic Society (ATS) Annual Meeting May 2022 poster: “Identification of Clinical Deterioration Risk in COVID-19 (CASCADE)”
Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 presentation: “Comparison of topical nomacopan, a dual complement and leukotriene LTB4 inhibitor, with dexamethasone in downregulating experimental immune-mediated conjunc
Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 2022 poster: “Development of long-acting PAS-nomacopan for treatment of GA and other retinal diseases
